cGMP Manufacturing
We offer a variety of scales and services for mammalian cell culture, microbial fermentation, cell therapy, and viral vectors

AGC Biologics has successfully manufactured more than 200 biological projects for pre-clinical studies through commercial approvals. Our teams of scientists at our cell and viral vector gene therapy sites have more than two decades of manufacturing experience.
Our seven state-of-the-art facilities across the globe offer innovative design, expanding capacity, technological ingenuity, and teams dedicated to strict biopharmaceutical regulations required for cGMP operations.
Related Resources
- Fact Sheet: Global Manufacturing Capabilities (PDF)

Mammalian
We have developed more than 60 mammalian cell lines and processes from pre-clinical through commercial production.

Microbial
We have successfully expressed antibody fragments, growth factors, antigens, enzymes, and other proteins using multiple modes of expression.

Cell Therapy
Our global cell therapy services are backed by teams with 25 years of expertise, and the latest systems and technology.

Viral Vector
We are building innovative and proprietary AAV, LVV, and RVV systems that meet the latest industry needs that can support any product platform.

mRNA
We offer supplies in different qualities, and development scales and have extensive in-house analytical methods for today's latest applications.

pDNA
Our non-GMP or GMP supply of material supports vaccine creation, RNA drugs, gene therapy and viral vector starting materials, and more.